Charles Evan Ballantyne

CIK 1371742 · View on SEC EDGAR ↗

Insider

First SEC filing: April 12, 2023 · Latest: April 12, 2023

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 9 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

9 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Sept. 25, 2015 AGEN P 10,000 $5.05 $50,500 10,000 Direct Acquired -92.1% (price as of 2026-08-21)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
April 10, 2023 GANX Restricted Stock Units Common Stock (50,000) 50,000 Acquired
April 10, 2023 GANX Employee Stock Option (right to buy) Common Stock (100,000) $4.79 April 10, 2033 100,000 Acquired
June 14, 2016 AGEN Stock Option, right to buy Common Stock (75,000) $4.16 March 31, 2026 75,000 Acquired
June 14, 2016 AGEN Restricted Stock Unit Common Stock March 31, 2019 14,000 Acquired
June 17, 2015 AGEN Stock Option, right to buy Commmon Stock (150,000) $9.78 June 17, 2025 150,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2016 $235,981 $483,876
2015 $179,038 $86,100 $1,425,944

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.